[artículo] 
inThe Journal of Clinical Psychiatry > Año 2011 - Vol.72 - No.1 (Enero) . - pp. 98-113

Título :	Placebo controlled, antidepressant clinical trials cannot be shortened to less than 4 weeks' duration : a pooled analysis of randomized clinical trials employing a diagnostic odds ratio based approach
Tipo de documento:	texto impreso
Autores:	Enrico Tedeschini, Autor ; Maurizio Fava, Autor ; George I. Papakostas, Autor
Fecha de publicación:	2022
Artículo en la página:	pp. 98-113
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Antidepresivos, Trastorno depresivo mayor, Ensayos controlados aleatorios.
Resumen:	In double-blind, randomized, placebo-controlled clinical trials for major depressive disorder (MDD), the impact of study duration on outcome has not been adequately studied. Our aim was to examine whether placebo-controlled antidepressant trials in MDD could be shortened to less than 4 weeks.
Link:	./index.php?lvl=notice_display&id=27932

[artículo] Placebo controlled, antidepressant clinical trials cannot be shortened to less than 4 weeks' duration : a pooled analysis of randomized clinical trials employing a diagnostic odds ratio based approach [texto impreso] / Enrico Tedeschini, Autor ; Maurizio Fava, Autor ; George I. Papakostas, Autor . - 2022 . - pp. 98-113.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in The Journal of Clinical Psychiatry > Año 2011 - Vol.72 - No.1 (Enero) . - pp. 98-113

Palabras clave:	Antidepresivos, Trastorno depresivo mayor, Ensayos controlados aleatorios.
Resumen:	In double-blind, randomized, placebo-controlled clinical trials for major depressive disorder (MDD), the impact of study duration on outcome has not been adequately studied. Our aim was to examine whether placebo-controlled antidepressant trials in MDD could be shortened to less than 4 weeks.
Link:	./index.php?lvl=notice_display&id=27932